StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)
Stock analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research report issued on Saturday. The firm set a “sell” rating on the medical technology company’s stock. BIOLASE Stock Up 3.8 % BIOL stock opened at $0.01 on Friday. The firm has a 50 day moving average of […]
![StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/biolase-inc-logo-1200x675.png?v=20230125121206&w=240&h=240&zc=2)